References
1. Martinez FD. Early-Life Origins of Chronic Obstructive Pulmonary Disease. N Engl J Med 2016;375(9):871–878.
2. Bisgaard H, Jensen SM, Bønnelykke K. Interaction between asthma and lung function growth in early life. Am J Respir Crit Care Med 2012;185(11):1183–1189.
3. Strunk RC, Weiss ST, Yates KP, Tonascia J, Zeiger RS, Szefler SJ, CAMP Research Group. Mild to moderate asthma affects lung growth in children and adolescents. J Allergy Clin Immunol 2006;118(5):1040–1047.
4. Covar RA, Spahn JD, Murphy JR, Szefler SJ, Childhood Asthma Management Program Research Group. Progression of asthma measured by lung function in the childhood asthma management program. Am J Respir Crit Care Med 2004;170(3):234–241.
5. Lederer DJ, Bell SC, Branson RD, Chalmers JD, Marshall R, Maslove DM, Ost DE, Punjabi NM, Schatz M, Smyth AR, et al. Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals. Ann Am Thorac Soc 2019;16(1):22–28.
6. O’Byrne PM, Pedersen S, Lamm CJ, Tan WC, Busse WW, START Investigators Group. Severe exacerbations and decline in lung function in asthma. Am J Respir Crit Care Med 2009;179(1):19–24.
7. Mahut B, Peyrard S, Delclaux C. Exhaled nitric oxide and clinical phenotypes of childhood asthma. Respir Res 2011;12:65.
8. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CPM, Gustafsson P, et al. Standardisation of spirometry. Eur Respir J 2005;26(2):319–338.
9. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MSM, Zheng J, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 2012;40(6):1324–1343.
10. Quanjer PH, Weiner DJ. Interpretative consequences of adopting the Global Lungs 2012 reference equations for spirometry for children and adolescents. Pediatr Pulmonol 2014;49(2):118–125.
11. Denlinger LC, Phillips BR, Sorkness RL, Bleecker ER, Castro M, DeBoer MD, Fitzpatrick AM, Hastie AT, Gaffin JM, Moore WC, et al. Responsiveness to Parenteral Corticosteroids and Lung Function Trajectory in Adults with Moderate to Severe Asthma. Am J Respir Crit Care Med 2020 Dec 8.
12. Mahut B, Trinquart L, Bokov P, Peiffer C, Delclaux C. Lung function impairment evidenced by sequential specific airway resistance in childhood persistent asthma: a longitudinal study. J Asthma 2010;47(6):655–659.
13. Sears MR, Greene JM, Willan AR, Wiecek EM, Taylor DR, Flannery EM, Cowan JO, Herbison GP, Silva PA, Poulton R. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003;349(15):1414–1422.
14. McGeachie MJ, Yates KP, Zhou X, Guo F, Sternberg AL, Van Natta ML, Wise RA, Szefler SJ, Sharma S, Kho AT, et al. Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma. N Engl J Med 2016;374(19):1842–1852.
15. Sharma S, Litonjua AA, Tantisira KG, Fuhlbrigge AL, Szefler SJ, Strunk RC, Zeiger RS, Murphy AJ, Weiss ST, Childhood Asthma Management Program Research Group. Clinical predictors and outcomes of consistent bronchodilator response in the childhood asthma management program. J Allergy Clin Immunol 2008;122(5):921-928.e4.
16. Bui DS, Perret JL, Walters EH, Abramson MJ, Burgess JA, Bui MQ, Bowatte G, Lowe AJ, Russell MA, Alif SM, et al. Lifetime Risk Factors for Pre- and Post-Bronchodilator Lung Function Decline. A Population-based Study. Ann Am Thorac Soc 2020;17(3):302–312.
17. Mogensen I, Vonk JM, Wijnant SRA, Zhou X, Boezen HM, Brusselle G, Lahousse L, Janson C, Malinovschi A. Blood eosinophil level and lung function trajectories: cross-sectional and longitudinal studies in European cohorts. ERJ Open Res 2020;6(4).
18. van Rensen ELJ, Sont JK, Evertse CE, Willems LNA, Mauad T, Hiemstra PS, Sterk PJ, AMPUL Study Group. Bronchial CD8 cell infiltrate and lung function decline in asthma. Am J Respir Crit Care Med 2005;172(7):837–841.
19. Ulrik CS. Outcome of asthma: longitudinal changes in lung function. Eur Respir J 1999;13(4):904–918.
20. Mahut B, Beydon N, Delclaux C. Overweight is not a comorbidity factor during childhood asthma: the GrowthOb study. Eur Respir J 2012;39(5):1120–1126.
21. Graff S, Bricmont N, Moermans C, Henket M, Paulus V, Guissard F, Louis R, Schleich F. Clinical and biological factors associated with irreversible airway obstruction in adult asthma. Respir Med 2020;175:106202.
22. Tantisira KG, Fuhlbrigge AL, Tonascia J, Van Natta M, Zeiger RS, Strunk RC, Szefler SJ, Weiss ST, Childhood Asthma Management Program Research Group. Bronchodilation and bronchoconstriction: predictors of future lung function in childhood asthma. J Allergy Clin Immunol 2006;117(6):1264–1271.
23. Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, Adcock IM, Bateman ED, Bel EH, Bleecker ER, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2014;43(2):343–373.
24. Song WJ, Lee JH, Kang Y, Joung WJ, Chung KF. Future Risks in Patients With Severe Asthma. Allergy Asthma Immunol Res 2019;11(6):763–778.
25. Bui DS, Lodge CJ, Burgess JA, Lowe A, Perret J, Bui MQ, Bowatte G, Gurrin L, Johns DP, Thompson BR, et al. Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life. 544 2018 Jul 1 [accessed 2020 Oct 19]. http://spiral.imperial.ac.uk/handle/10044/1/57288
26. Reddel HK, Taylor DR, Bateman ED, Boulet L-P, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009;180(1):59–99.
Table 1. Characteristics of the 295 asthmatic children according to the three groups of FEV1 % predicted slope.